Stem Cells in the News

Stem cells aren't a miracle cure, but they've come a long way.
The breakthroughs of the last decade are the result of rigorous research, global investment, and a growing body of peer-reviewed evidence across both human and veterinary medicine. This page brings together a selection of news stories and studies that highlight the breadth and potential of stem cell science today.

VetStem has now administered 40,000 treatments over in the USA.

US-based VetStem, Inc. has processed more than 40,000 stem cell treatments, underscoring the proven safety of this therapy.

Stem cells reverse woman's diabetes a world first

In a world first, scientists have successfully used stem cell therapy to reverse type 1 diabetes in a woman.

Meet the grandma gorilla receiving world-first medical treatment for arthritis

A grandma gorilla has been given a new medical treatment to help with her achy knees and joints in a medical world-first.

Stem cell therapy brings new hope to cat at risk of blindness

Lokum, a cat with progressive retinal atrophy (PRA) causing vision loss, showed improvement after two stem cell treatments given two weeks apart. Ask ChatGPT

Adding stem cells to a kidney transplant could get patients off anti-rejection drugs, trial finds

A novel approach to organ transplantation allowed patients to wean off anti-rejection drugs after two years, according to the results of a phase 3 clinical trial presented Monday.

A New Technique Uses a Patient’s Own Stem Cells to Restore Their Vision

In 2020, Nick Kharufeh lost sight in one eye after a fireworks accident. A trial used limbal stem cells from his healthy eye, grown in a lab, to treat the injury.

New ‘smart’ immune cells: a breakthrough for long-lasting tumor destruction

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors, a smart fighter that destroys cancer cells for days without tiring.

Ryoncil, the first FDA-approved mesenchymal stromal cell therapy

The multipotent characteristics of MSCs have the potential to expand into multiple human clinical developments.